Metabolic rather than pathological response to preoperative chemoradiotherapy is a stronger predictor of survival in cStage IIB-IV esophageal cancer

Anticancer Research

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2tBHqSz
via IFTTT